enVVeno Medical reports Q2 EPS (31c) vs. (58c) last year
PremiumThe FlyenVVeno Medical reports Q2 EPS (31c) vs. (58c) last year
2M ago
enVVeno Medical presents interim venous ulcer healing data
Premium
The Fly
enVVeno Medical presents interim venous ulcer healing data
3M ago
enVVeno Medical to present interim data from VenoValve trial
Premium
The Fly
enVVeno Medical to present interim data from VenoValve trial
4M ago
enVVeno Medical appoints Andrew Cormack as CCO
PremiumThe FlyenVVeno Medical appoints Andrew Cormack as CCO
6M ago
NVNO Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
NVNO Earnings this Week: How Will it Perform?
6M ago
EnVVeno Medical’s VenoValve Trial Shows Promising Results
Premium
Company Announcements
EnVVeno Medical’s VenoValve Trial Shows Promising Results
7M ago
enVVeno Medical reports Q3 EPS (45c) vs. (54c) last year
PremiumThe FlyenVVeno Medical reports Q3 EPS (45c) vs. (54c) last year
11M ago
enVVeno Medical achieves full enrollment for VenoValve U.S. trial
Premium
The Fly
enVVeno Medical achieves full enrollment for VenoValve U.S. trial
12M ago
enVVeno Medical announces expedited development plan for enVVe valve
Premium
The Fly
enVVeno Medical announces expedited development plan for enVVe valve
12M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100